| Wed, Nov 25, 2009 | | • | Genzyme CEO Termeer Sells Company Shares
at Fox Business (Wed 4:13pm)
| | • | Dream Stocks for Biotech Investors
at Motley Fool (Wed 3:27pm)
| | • | Still Enjoying Those Acquisitions, Pfizer?
at Motley Fool (Wed 2:55pm)
| | • | UPDATE - Genzyme CEO sells 200,000 of company's shares
at Reuters (Wed 12:44pm)
| | • | Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate
at Seeking Alpha (Wed 7:31am)
| | • | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
GlobeNewswire (Wed 6:50am)
| | Tue, Nov 24, 2009 | | • | Shire moves to advance Gaucher drug
at bizjournals.com (Tue, Nov 24)
| | • | Biotech Stocks: Shire climbs, Pfizer falls in early trading
at MarketWatch (Tue, Nov 24)
| | • | Shire applies for Euro approval of Gaucher drug
at MarketWatch (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | Genzyme's Very Bad Year
at Seeking Alpha (Mon, Nov 23)
| | • | Top Takes From RealMoney
at TheStreet.com (Mon, Nov 23)
| | • | Icahn Makes Big Moves in Healthcare Stocks
Indie Research (Mon, Nov 23)
| | Fri, Nov 20, 2009 | | • | Wall Street's 10 Favorite Stocks Right Now
at Motley Fool (Fri, Nov 20)
| | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
| | • | Biotech Stock Mailbag: FDA Playbook
at TheStreet.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | Now's a Great Time to Invest -- So Don't Blow It Like This
at Motley Fool (Thu, Nov 19)
| | • | This Stock Is a Train Wreck
at Motley Fool (Thu, Nov 19)
| | • | Genzyme: Analysts' Upgrades, Downgrades
at TheStreet.com (Thu, Nov 19)
| | • | Genzyme's Problems Continue
Zacks.com (Thu, Nov 19)
| | • | Zacks #5 Rank Additions for Thursday
Zacks.com (Thu, Nov 19)
|
Add GENZ News to My Yahoo!:
 
| |
|
0.29% Nasdaq 
Headlines
